Wednesday, February 22, 2017 6:01:53 AM
"$1.6 Million Net" only to find that books were cooked buy using Fair Market Value of 172 Million shares as "revenue".
"$80 Million" in revenues, only to find out that OMHE is projecting at $6 mil/year - for a single pharmacy that is generating 40% of an average CVS; which generates ~$15 mil/store
"Net Profits", only to find out after removing the FMV of 172 million shares, that OMHE has operational losses.
At LEAST 2 more quarters of operational losses.
8 Months Later
2/9/17 - 8 months later, all OMHE can muster is that they plan on planning new divisions.
http://finance.yahoo.com/news/omni-health-inc-issues-letter-120000190.html
and resulting in
Bait and No Execute Working Out Brilliantly. The delay tactics are working. The vague terminology is working exactly as planned. They're going to milk "licensed medical marijuana cultivation" for at least a couple of years.
"Anti-aging" cream = Le Signature - a crap product that Andrey owns, and has only managed to "sell" ONE wholesale account since 2014.
"therapeutic cannabis products" = retailing low margin CBD; and likely losing slotting fees via the MOQ w/ MCIG.
"licensed medical marijuana cultivation" = vague terminology on purpose.
No MJ Dispensary specified.
No MJ Cultivation site specified
No MJ Lab specified
More likely than not, just means no marijuana at all.
OMHE has $1.8 million in debt
OMHE is running out of cash by April 2017
OMHE has operational losses
OMHE just announced they have increased costs
More debt/dilution is imminent.
They're going to bait, delay, dilute, and pay its consultants like Andrey, Hawkins, and Paul The SHYSTER.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM